β2-Adrenergic receptor responsiveness of the calpain-calpastatin system and attenuation of neuronal death in rat hippocampus after transient global ischemia

Neuroscience Research

Volumn 47, Issue 4, 2003, Pages 373-382

  Rami, A ^a   Volkmann, T ^a   Agarwal, R ^a   Schoninger, S ^a   Nurnberger F ^a   Saido, T C ^b   Winckler, J ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Apoptosis; Calpain calpastatin system; Cerebral ischemia; Clenbuterol; Hippocampus; Spectrin breakdown products

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; CALPAIN; CALPASTATIN; CLENBUTEROL; DNA FRAGMENT; NEUROPROTECTIVE AGENT; SPECTRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATTENUATION; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOLOCALIZATION; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; TRANSIENT ISCHEMIC ATTACK;

EID: 0242551707     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2003.07.002     Document Type: Article

References (36)

1. Adamec E., Mohan P., Vonsattel J.P., Nixon R.A. Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form af calpain 2. Acta Neuropathol. 104:2002;92-104.
2. Bardsley R.G., Allcock S.M., Dawson J.M., Dumelow N.W., Higgins J.A., Lasslett Y.V., Lockley A.K., Parr T., Buttery P.J. Effect of beta-agonists on expression of calpain and calpastatin activity in skeletal muscle. Biochimie. 74:1992;267-273.
3. Blomgren K., Hallin U., Andersson A.L., Puka-Sundvall M., Bahr B.A., McRae A., Saido T.C., Kawashima S., Hagberg H. Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia. J. Biol. Chem. 274:1999;14046-14052.
4. Bohorov O., Buttery P.J., Correia J.H., Soar J.B. The effect of the beta-2-adrenergic agonist clenbuterol or implantation with oestradiol plus trenbolone acetate on protein metabolism in weather lambs. Br. J. Nutr. 57:1987;99-107.
5. Choi J.M., Shin H.K., Kim K.Y., Lee J.H., Hong K.W. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. J. Pharmacol. Exp. Ther. 300:2002;787-793.
6. Cong M., Goll D.E., Antin P.B. cAMP responsiveness of the bovine calpastatin gene promoter. Biochim. Biophys. Acta. 1443:1998;186-192.
7. Culmsee C., Stumm R.K., Schafer M.K., Weihe E., Krieglstein J. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur. J. Pharmacol. 379:1999;33-45.
8. DeMartino G.N., Croall D.E. Calcium-dependent proteases from liver and heart. Prog. Clin. Biol. Res. 180:1984;117-126.
9. Eto A., Akita Y., Saido T.C., Suzuki K., Kawashima S. The role of the calpain-calpastatin system in thyrotropin-releasing hormone-induced selective down-regulation of a protein kinase C isozyme, nPKC epsilon, in rat pituitary GH4C1 cells. J. Biol. Chem. 270:1995;25115-25120.
10. Fukuda S., Harada K., Kunimatsu M., Sakabe T., Yoshida K. Postischemic reperfusion induces alpha-fodrin proteolysis by m-calpain in the synaptosome and nucleus in rat brain. J. Neurochem. 70:1998;2526-2532.
11. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA-fragmentation. J. Cell. Biol. 119:1992;493-501.
12. Ishida S., Emori Y., Suzuki K. Rat calpastatin has diverged primary sequence from other mammalian calpastatins but retains functionally important sequences. Biochim. Biophys. Acta. 1088:1991;436-438.
13. Kilmer S.L., Carlsen R.C. Chronic infusion of agents that increase cyclic AMP concentration enhances the regeneration of mammalian peripheral nerves in vivo. Exp. Neurol. 95:1987;357-367.
14. Lee W.J., Ma H., Takano E., Yang H.Q., Hatanaka M., Maki M. Molecular diversity in amino-terminal domains of human calpastatin by exon skipping. J. Biol. Chem. 267:1992;8437-8442.
15. Maki M., Ma H., Takano E., Adachi Y., Lee W.J., Hatanaka M., Murachi T. Calpastatins: biochemical and molecular biological studies. Biomed. Biochim. Acta. 50:1991;509-516.
16. Maltin C.A., Delday M.I., Watson J.S., Heys S.D., Nevison I.M., Ritchie I.K., Gibson P.H. Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin. Sci. 84:1993a;651-654.
17. Maltin C.A., Jones P., Mantle D. Effect of protease inhibitors and clenbuterol on the in vitro degradation of dystrophin by endogenous proteases in human skeletal muscle. Biosci. Rep. 13:1993;159-167.
18. Mersmann H.J. Overview of the effects of beta-adrenergic receptor agonists on animal growth including mechanisms of action. J. Anim. Sci. 76:1998;160-172.
19. Nakao N. An increase in intracellular levels of cyclic AMP produces trophic effects on striatal neurons developing in culture. Neuroscience. 82:1998;1009-1020.
20. Neuberger T., Chakrabarti A.K., Russell T., DeVries G.H., Hogan E.L., Banik N.L. Immunolocalization of cytoplasmic and myelin m-calpain in transfected Schwann cells: I. Effect of treatment with growth factors. J. Neurosci. Res. 47:1997;521-530.
21. Neumar R.W., Xu Y.A., Gada H., Guttmann R.P., Siman R. Cross-talk between calpain and caspase proteolytic systems during neuronal apoptosis. J. Biol. Chem. 278:2003;14162-14167.
22. Oshima M., Koizumi S., Fujita K., Guroff G. Nerve growth factor-induced decrease in the calpain activity of PC12 cells. J. Biol. Chem. 264:1989;20811-20816.
23. Parr T., Bardsley R.G., Gilmour R.S., Buttery P.J. Changes in calpain and calpastatin mRNA induced by beta-adrenergic stimulation of bovine skeletal muscle. Eur. J. Biochem. 208:1992;333-339.
24. Rami A. Cross-Talk between calpain and caspase-3 in response to cerebral ischemia. Restor. Neurol. Neurosci. 16:2000;63.
25. Rami A. Calpain and caspase in cerebral ischemia and neuronal apoptosis: the "calpain-calpastatin-caspase-hypothesis" Neurobiol. Dis. 13:2003;75-88.
26. Rami A., Agarwal R., Botez G., Winckler J. μ-Calpain Activation, DNA-Fragmentation, and synergistic effects of caspase- and calpain-inhibitors in protecting hippocampal neurons from ischemic damage. Brain Res. 866:2000;299-312.
27. Saido T.C., Yokota M., Nagao N., Yamaura I., Tani E., Tsuchiya T., Suzuki K., Kawashima S. Spatial resolution of spectrin proteolysis in postischemic brain. J. Biol. Chem. 25:1993;25239-25243.
28. Saido T.C., Sorimachi H., Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8:1994;814-822.
29. Saido T.C., Kwashima S., Tani E., Yokta M. Up- and downregulation of calpain inhibitor polypeptide, calpastatin, in postischemic hippocampus. Neurosci. Lett. 227:1997;756-778.
30. Seubert P., Lee K., Lynch G. Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res. 492:1989;366-370.
31. Semkova I., Krieglstein J. Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res. Brain Res. Rev. 30:1999;176-188.
32. Semkova I., Schilling M., Henrich-Noack P., Rami A., Krieglstein J. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res. 717:1996;44-54.
33. Smith M.L., Bendek G., Dahgren N., Rosén I., Wieloch T., Siesjö B.K. Models for studying long-term recovery following forebrain ischemia in the rat. A 2-vessel occlusion model. Acta. Neurol. Scand. 69:1984;385-401.
34. Sorimashi H., Ishiura S., Suzuki K. Structure and physiological function of calpains. Biochem. J. 328:1997;721-732.
35. Zeman R.J., Feng Y., Peng H., Etlinger J.D. Clenbuterol, a beta(2)-adrenoceptor agonist, improves locomotor and histological outcomes after spinal cord contusion in rats. Exp. Neurol. 159:1999;267-273.
36. Zhu Y., Prehn J.H., Culmsee C., Krieglstein J. The beta2-adrenoceptor agonist clenbuterol modulates Bcl-2, Bcl-xl and Bax protein expression following transient forebrain ischemia. Neuroscience. 90:1999;1255-1263.